Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2025	Jan. 31, 2024	Jan. 31, 2023
Cash flows from operating activities
Net loss	$ (81,935)	$ (75,569)	$ (105,551)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	9,236	6,622	5,290
Non-cash lease expense	4,399	4,318	4,727
Amortization of contract acquisition costs	17,524	17,770	16,943
Stock-based compensation expense	59,366	64,348	83,859
Loss on extinguishment of debt	1,850	0	0
Remeasurement of warrant liability	150	0	0
Other, net	6,209	4,735	6,768
Change in operating assets and liabilities:
Accounts receivable, net	(4,347)	11,761	(14,809)
Contract acquisition costs	(17,492)	(15,324)	(16,999)
Prepaid expenses and other	123	(1,593)	2,390
Accounts payable	1,829	(6,974)	6,947
Operating lease liabilities	(5,334)	(5,177)	(6,179)
Accrued expenses and other liabilities	6,252	(4,438)	(9,403)
Deferred revenue	(6,882)	2,104	15,127
Net cash (used in) provided by operating activities	(9,052)	2,583	(10,890)
Cash flows from investing activities
Purchases of property and equipment	(9,445)	(11,734)	(7,996)
Purchases of intangible assets	0	(26)	0
Net cash used in investing activities	(9,445)	(11,760)	(7,996)
Cash flows from financing activities
Payments of deferred offering costs for registration statement	(1,003)	0	0
Proceeds from shares issued in connection with employee stock purchase plan	1,910	3,406	1,563
Shares repurchased for tax withholdings on vesting of restricted stock	(820)	0	0
Debt proceeds, net of issuance costs	52,758	0	0
Repayment of debt and related fees	(53,177)	0	0
Proceeds from short-term payable financing	12,694	0	6,624
Payments on short-term payable financing	(8,971)	0	(6,624)
Proceeds from exercise of stock options	0	65	861
Net cash provided by financing activities	3,391	3,471	2,424
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(569)	145	(599)
Net decrease in cash, cash equivalents, and restricted cash	(15,675)	(5,561)	(17,061)
Cash, cash equivalents, and restricted cash at beginning of period	60,939	66,500	83,561
Cash, cash equivalents, and restricted cash at end of period	45,264	60,939	66,500
Supplemental disclosures of cash flow information
Cash paid for income taxes, net of refunds	1,166	577	309
Cash paid for interest	12,117	12,593	9,111
Non-cash investing and financing activities
Operating lease right-of-use assets obtained for lease liabilities	2,863	806	4,608
Purchases of property and equipment included in accounts payable and lease liabilities	416	329	1,275
Stock-based compensation capitalized as internal-use software	2,406	2,509	1,583
Debt issuance costs in accounts payable and accrued liabilities	206	0	0
Deferred offering costs for registration statement in accounts payable and accrued liabilities	164	0	0
Issuance of warrants in connection with credit facility	$ 11,058	$ 0	$ 0